Jon Faiz Kayyem
GenMark Diagnostics' Founder Jon Faiz Kayyem is transitioning from his position as head of R&D to become a technical and strategic advisor to its management team and board of directors. Kayyem is the inventor of the firm's eSensor electronic detection technology and led the development of its ePlex multiplex platform. Kayyem noted during a company presentation Tuesday that he will now "endeavor to add value in new ways beyond ePlex."
BioMérieux has appointed Guillaume Bouhours as corporate vice-president, CFO, and a member of its executive committee. He replaces Claire Giraut, who is retiring, and will head the firm's finance, purchasing, and information systems departments. Bouhours was previously CFO at Faiveley Transport, a railway equipment manufacturer based in France.
Frank Williams, cofounder and CEO of value-based care management company Evolent Health, has been named to the board of directors of precision oncology technology of vendor Syapse. Syapse said that Williams, a former CEO of the Advisory Board Company, will be able to offer strategic advice as the company expands its reach. Since late November, Syapse has raised $30 million in new investment, hired a new VP of oncology, entered into a partnership with Roche, and entered the Asian market.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.